The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Treatment of substance abusing patients with comorbid psychiatric disorders
Open accessAbstract
Objective To update clinicians on the latest in evidence-based treatments for substance use disorders (SUD) and non-substance use disorders among adults and suggest how these treatments can be combined into an evidence based process that enhances treatment effectiveness in comorbid patients. Method Articles were extracted from Pubmed using the search terms “dual diagnosis,” “comorbidity” and “co-occurring” and were reviewed for evidence of effectiveness for pharmacologic and psychotherapeutic treatments of comorbidity. Results Twenty-four research reviews and 43 research trials were reviewed. The preponderance of the evidence suggests that antidepressants prescribed to improve substance-related symptoms among patients with mood and anxiety disorders are either not highly effective or involve risk due to high side-effect profiles or toxicity. Second-generation antipsychotics are more effective for treatment of schizophrenia and comorbid substance abuse and current evidence suggests clozapine, olanzapine and risperidone are among the best. Clozapine appears to be the most effective of the antipsychotics for reducing alcohol, cocaine and cannabis abuse among patients with schizophrenia. Motivational interviewing has robust support as a highly effective psychotherapy for establishing a therapeutic alliance. This finding is critical since retention in treatment is essential for maintaining effectiveness. Highly structured therapy programs that integrate intensive outpatient treatments, case management services and behavioral therapies such as Contingency Management (CM) are most effective for treatment of severe comorbid conditions. Conclusions Creative combinations of psychotherapies, behavioral and pharmacological interventions offer the most effective treatment for comorbidity. Intensity of treatment must be increased for severe comorbid conditions such as the schizophrenia/cannabis dependence comorbidity due to the limitations of pharmacological treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Motivational interviewing: preparing people for change.
Miller, W. R., & Rollnick, S. (2002) · Guilford Press eBooks · Cited by 7,000
(1991) · Medical Entomology and Zoology · Cited by 4,438
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review
Martin, D. J., Garske, J. P., & Davis, M. K. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.3.438 · Cited by 3,355
Defining empirically supported therapies.
Chambless, D. L., & Hollon, S. D. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.7 · Cited by 3,067
Relation between working alliance and outcome in psychotherapy: A meta-analysis
Horvath, A. O., & Symonds, B. D. (1991) · Journal of Counseling Psychology · doi:10.1037/0022-0167.38.2.139 · Cited by 2,673
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Regier, D. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800350011002 · Cited by 1,737
(1992) · PubMed · Cited by 1,429
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 15×
“Therefore, while OCD is quite impairing it is being overlooked in designing treatment studies for mood and anxiety disorders, thereby reducing the volume of treatment studies on its comorbidity with substance use diosrders.”
InfluentialNorcross, J. C., Krebs, P. M., & Prochaska, J. O. (2011) · Journal of Clinical Psychology · doi:10.1002/jclp.20758 · Cited by 1,065
Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature
Jacobsen, L. K., Southwick, S. M., & Kosten, T. R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1184 · Cited by 1,041
Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., Sampson, N., & Kessler, R. C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02902.x · Cited by 597
Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three‐Year Drinking Outcomes
Project MATCH Research Group (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03912.x · Cited by 578
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Gyulai, L., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.419 · Cited by 537
Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes, E. V., & Levin, F. R. (2004) · JAMA · doi:10.1001/jama.291.15.1887 · Cited by 532
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder
Frank, E., Swartz, H. A., & Kupfer, D. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00969-0 · Cited by 521 · cited 3×
“Outcome studies indicate that IPSRT is more effective for preventing relapse, improving functioning in relationships, and increasing life satisfaction than medication management alone (Chambless & Hollon, 1998; Miklowitz et al., 2007; Miklowitz et al., 2007).”
Mills, K. L., Teesson, M., Ross, J., & Peters, L. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.652 · Cited by 519
Development of lifetime comorbidity in the World Health Organization world mental health surveys
Kessler, R. C., Ormel, J., Petukhova, M., McLaughlin, K. A., Green, J. G., Russo, L. J., Stein, D. J., Zaslavsky, A. M., Aguilar-Gaxiola, S., Alonso, J., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.180 · Cited by 508
Major depression and comorbid substance use disorders
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f32408 · Cited by 498
JANE-LLOPIS, E., & MATYTSINA, I. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944461 · Cited by 497
Stewart, R. E., & Chambless, D. L. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016032 · Cited by 483 · cited 1×
“Behavioral and Psychotherapy of Anxiety Disorders CBT has been found to be highly effective against anxiety associated with all DSM-defined anxiety disorders, as long as therapists are well-trained and supervised and use manualbased therapies (Hofmann & Smits, 2008; Stewart & Chambless, 2009).”
Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2004.360.374 · Cited by 459
Bromet, E., Sonnega, A., & Kessler, R. C. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009457 · Cited by 370
Petry, N. M., Peirce, J. M., Stitzer, M. L., Blaine, J., Roll, J. M., Cohen, A., Obert, J., Killeen, T., Saladin, M. E., Cowell, M., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1148 · Cited by 369
Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three-Year Drinking Outcomes
(1998) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199809000-00016 · Cited by 360
Fluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 357
Fazel, S., Lichtenstein, P., Grann, M., Goodwin, G. M., & Långström, N. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.97 · Cited by 355
A Randomized Effectiveness Trial of Stepped Collaborative Care forAcutely Injured Trauma Survivors
Zatzick, D., Roy-Byrne, P., Russo, J., Rivara, F., Droesch, R., Wagner, A., Dunn, C., Jurkovich, G., Uehara, E., & Katon, W. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.498 · Cited by 350
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336
A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder
Milrod, B., Leon, A. C., Busch, F., Rudden, M., Schwalberg, M., Clarkin, J., Aronson, A., Singer, M., Turchin, W., Klass, E. T., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.265 · Cited by 323
Mood Disorders and Substance Use Disorder: A Complex Comorbidity
Quello, S., Brady, K., & Sonne, S. (2005) · Science & Practice Perspectives · doi:10.1151/spp053113 · Cited by 320
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317 · cited 1×
“Ravindran and Stein (2010) and Pittenger and colleagues (2005) have conducted thorough reviews and report that cloimipramine was first found to be effective against OCD but that its high side-effect profile has limited its use in clinical practice.”
Motivational Interviewing and the Stages of Change
DiClemente, C. C., & Velasquez, M. M. (2005) · Cited by 315
Does retention matter? Treatment duration and improvement in drug use
Zhang, Z., Friedmann, P. D., & Gerstein, D. R. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00354.x · Cited by 314
Hien, D. A., Jiang, H., Campbell, A. N. C., Hu, M.-C., Miele, G. M., Cohen, L. R., Brigham, G. S., Capstick, C., Kulaga, A., Robinson, J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09091261 · Cited by 309
Peirce, J. M., Petry, N. M., Stitzer, M. L., Blaine, J., Kellogg, S., Satterfield, F., Schwartz, M., Krasnansky, J., Pencer, E., Silva-Vazquez, L., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.201 · Cited by 304
Exposure therapy in the treatment of PTSD among cocaine-dependent individuals
Brady, K. T., Dansky, B. S., Back, S. E., Foa, E. B., & Carroll, K. M. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00182-9 · Cited by 297
Theory-based active ingredients of effective treatments for substance use disorders
Moos, R. H. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.10.010 · Cited by 292
Hien, D. A., Wells, E. A., Jiang, H., Suarez-Morales, L., Campbell, A. N. C., Cohen, L. R., Miele, G. M., Killeen, T., Brigham, G. S., Zhang, Y., et al. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016227 · Cited by 287
Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.426 · Cited by 285
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Kogan, J. N., Sachs, G. S., Thase, M. E., Calabrese, J. R., Marangell, L. B., Ostacher, M. J., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020311 · Cited by 274
Salloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.37 · Cited by 271
Self-citationEfficacy of antidepressants in substance use disorders with and without comorbid depression
Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 261
Mason, B. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530340025025 · Cited by 257
Buspirone Treatment of Anxious Alcoholics: A Placebo-Controlled Trial
Kranzler, H. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090052008 · Cited by 248
Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
A. Johnson, B., & Ait-Daoud, N. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516404 · Cited by 247
Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., Davies, L., Dunn, G., Eisner, E., Lewis, S., et al. (2010) · BMJ · doi:10.1136/bmj.c6325 · Cited by 245
Pharmacologic treatment of anxiety disorders.
MAVISSAKALIAN, M. R. (1982) · PubMed · Cited by 243
Kadden, R. M., Kathleen, C., Donovan, D. M., Cooney, N. L., Monti, P. M., Abrams, D. B., Litt, M. D., & Hester, R. K. (2003) · Cited by 241
The Link Between Substance Abuse and Posttraumatic Stress Disorder in Women: A Research Review
Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1997) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1997.tb00408.x · Cited by 240
Horsfall, J., Cleary, M., Hunt, G. E., & Walter, G. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902724599 · Cited by 234
Schneier, F. R., Foose, T. E., Hasin, D. S., Heimberg, R. G., Liu, S.-M., Grant, B. F., & Blanco, C. (2010) · Psychological Medicine · doi:10.1017/s0033291709991231 · Cited by 225
Cannabis use and misuse prevalence among people with psychosis
Green, B., Young, R., & Kavanagh, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.4.306 · Cited by 215
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
Hetrick, S. E., Purcell, R., Garner, B., & Parslow, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007316.pub2 · Cited by 212
Guidelines for the Systematic Treatment of the Depressed Patient
Beutler, L. E., Clarkin, J., & Bongar, B. (2000) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195105308.001.0001 · Cited by 206
(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 206
Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 198
ZIEDONIS, D. M., SMELSON, D., ROSENTHAL, R. N., BATKI, S. L., GREEN, A. I., HENRY, R. J., MONTOYA, I., PARKS, J., & WEISS, R. D. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200509000-00005 · Cited by 195
Paroxetine efficacy in the treatment of generalized anxiety disorder
Rocca, P., Fonzo, V., Scotta, M., Zanalda, E., & Ravizza, L. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09660.x · Cited by 194
Schäfer, I., & Najavits, L. M. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f0ffd9 · Cited by 193
Randall, C. L., Thomas, S., & Thevos, A. K. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02201.x · Cited by 188
Substance Dependence Posttraumatic Stress Disorder Therapy
Triffleman, E., Carroll, K., & Kellogg, S. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00067-1 · Cited by 178
New treatments for cocaine dependence: a focused review
Karila, L., Gorelick, D., Weinstein, A., Noble, F., Benyamina, A., Coscas, S., Blecha, L., Lowenstein, W., Martinot, J. L., Reynaud, M., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008097 · Cited by 178
The COMBINE Study Research Group (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb02873.x · Cited by 174
Easton, C. J., Mandel, D. L., Hunkele, K. A., Nich, C., Rounsaville, B. J., & Carroll, K. M. (2007) · The American Journal on Addictions · doi:10.1080/10550490601077809 · Cited by 173
Coffey, S. F., Stasiewicz, P. R., Hughes, P. M., & Brimo, M. L. (2006) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.20.4.425 · Cited by 172 · cited 2×
“Cravings for substances increase among PTSD patients in response to trauma-related cues and one treatment study found that patients who received a course of imaginal exposure therapy reported less distress and decreased alcohol cravings compared to a control group (Coffey et al., 2005; Coffey et al., 2006; Saladin et…”
Treatments for Patients With Dual Diagnosis: A Review
Tiet, Q. Q., & Mausbach, B. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00336.x · Cited by 169
Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D., Ocepek-Welikson, K., Koenig, T., Brady, R., McGrath, P. J., & Woody, G. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.153 · Cited by 164
Fallot, R. D., & Harris, M. (2002) · Community Mental Health Journal · doi:10.1023/a:1020880101769 · Cited by 162
WOODY, G. E., O’Brien, C. P., & Rickels, K. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.4.447 · Cited by 155
Meta‐analysis of depression and substance use and impairment among intravenous drug users (IDUs)
Conner, K. R., Pinquart, M., & Duberstein, P. R. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02118.x · Cited by 154
PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime
Saladin, M. E., Drobes, D. J., Coffey, S. F., Dansky, B. S., Brady, K. T., & Kilpatrick, D. G. (2003) · Addictive Behaviors · doi:10.1016/j.addbeh.2003.08.037 · Cited by 154
Sertraline in the Treatment of Co‐occurring Alcohol Dependence and Posttraumatic Stress Disorder
Brady, K. T., Sonne, S. C., Anton, R. F., Randall, C. L., Back, S. E., & Simpson, K. N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000156129.98265.57 · Cited by 152
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone
Green, A. I., Burgess, E. S., Dawson, R., Zimmet, S. V., & Strous, R. D. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00231-1 · Cited by 146
Bipolar disorder and substance abuse
LEVIN, F. R., & Hennessy, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.008 · Cited by 144
Teesson, M., Mills, K. L., Ross, J. E., Darke, S. G., Williamson, A. B., & Havard, A. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02029.x · Cited by 141
Antidepressant treatment of co-occurring depression and alcohol dependence
Pettinati, H. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.016 · Cited by 140
Efficacy of psychostimulant drugs for cocaine dependence.
Castells, X., Casas, M., Pérez-Mañá, C., Roncero, C., Vidal, X., & Capellà, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007380.pub3 · Cited by 136
Cognitive-behavioral therapy for the treatment of anxiety disorders.
Otto, M. W., Smits, J. A. J., & Reese, H. E. (2004) · PubMed · Cited by 136
Group Therapy for Patients With Bipolar Disorder and Substance Dependence
Weiss, R. D., Griffin, M. L., Greenfield, S. F., Najavits, L. M., Wyner, D., Soto, J. A., & Hennen, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0507 · Cited by 135
“Transcend”: Initial outcomes from a posttraumatic stress disorder/substance abuse treatment program
Donovan, B. S., Padin‐Rivera, E., & Kowaliw, S. (2001) · Journal of Traumatic Stress · doi:10.1023/a:1013094206154 · Cited by 132
Hesse, M. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-6 · Cited by 130
Barriers to the Use of Medications to Treat Alcoholism
Mark, T. L., Kranzler, H. R., Poole, V. H., Hagen, C. A., McLeod, C. C., & Crosse, S. B. (2003) · American Journal on Addictions · doi:10.1080/10550490390226879 · Cited by 126
Treatment of Cannabis Use Disorders: A Review of the Literature
Nordstrom, B. R., & LEVIN, F. R. (2007) · American Journal on Addictions · doi:10.1080/10550490701525665 · Cited by 125
Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys
Merikangas, K. R., & Kalaydjian, A. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281c61dc5 · Cited by 122
Fluoxetine treatment of cocaine-dependent patients with major depressive disorder
Schmitz, J. M., Averill, P. M., Stotts, A. L., Moeller, F. G., Rhoades, H. M., & Grabowski, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00208-8 · Cited by 121
Understanding US addiction physicians' low rate of naltrexone prescription
Mark, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00134-0 · Cited by 120
Marsden, J., Eastwood, B., Bradbury, C., Dale‐Perera, A., Farrell, M., Hammond, P., Knight, J., Randhawa, K., & Wright, C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61420-3 · Cited by 119
Simon, N. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.s.7002.02 · Cited by 118
The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt, J. C. (2009) · PubMed · Cited by 118
Moak, D. H., Anton, R. F., Latham, P. K., Voronin, K. E., Waid, R. L., & Durazo-Arvizú, R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095346.32154.41 · Cited by 114
Levin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K. (2004) · The American Journal on Addictions · doi:10.1080/10550490490265280 · Cited by 113
Cocaine dependence and PTSD: A pilot study of symptom interplay and treatment preferences
Back, S. E., Brady, K. T., Jaanimägi, U., & Jackson, J. L. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.05.008 · Cited by 109
Rubio, G., Martínez, I., Ponce, G., Jiménez‐Arriero, M. Á., Lopez-Munoz, F. J., & Álamo, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100808 · Cited by 109
Daley, D. C., Salloum, I. M., Zuckoff, A., Kirisci, L., & Thase, M. E. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1611 · Cited by 109
Self-citationPsychotherapy and substance abuse : a practitioner's handbook
Washton, A. M. (1995) · Guilford Press eBooks · Cited by 107
Back, S. E., Dansky, B. S., Carroll, K. M., Foa, E. B., & Brady, K. T. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00181-7 · Cited by 107
Effects of Baclofen on Cocaine Self-Administration: Opioid- and Nonopioid-Dependent Volunteers
Haney, M., Hart, C. L., & Foltin, R. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300999 · Cited by 107
Kemp, D. E., Gao, K., Ganocy, S. J., Elhaj, O., Bilali, S. R., Conroy, C., Findling, R. L., & Calabrese, J. R. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m04022 · Cited by 103
Supervised Disulfiram as Adjunct to Psychotherapy in Alcoholism Treatment
Krampe, H., & Ehrenreich, H. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516431 · Cited by 101
Epidemiology and Management of Alcohol Dependence in Individuals with Post-Traumatic Stress Disorder
McCarthy, E., & Petrakis, I. L. (2010) · CNS Drugs · doi:10.2165/11539710-000000000-00000 · Cited by 101
Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence
Smelson, D. A., LOSONCZY, M. F., Davis, C. W., Kaune, M., Williams, J. H. H., & Ziedonis, D. M. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700710 · Cited by 99
Treatment of Cannabis Use Among People With Psychotic or Depressive Disorders
Baker, A., Hides, L. M., & Lubman, D. I. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05119gry · Cited by 98
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Milrod, B. L. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.2.265 · Cited by 96
Imipramine treatment of cocaine abuse: possible boundaries of efficacy
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Ocepek‐Welikson, K., Stewart, J. W., Koenig, T., Wager, S., & Klein, D. F. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01161-6 · Cited by 95
James, W., Preston, N. J., Koh, G. C., SPENCER, C., Kisely, S. R., & Castle, D. J. (2004) · Psychological Medicine · doi:10.1017/s0033291703001648 · Cited by 93
Alcohol and Psychiatric Comorbidity
Cornelius, J. R., Bukstein, O. G., Salloum, I. M., & Clark, D. B. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_24 · Cited by 91
Schad, A., Marquenie, L. A., van Balkom, A. J. L. M., Koeter, M. W. J., de Beurs, E., van den Brink, W., & van Dyck, R. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000163511.24583.33 · Cited by 90
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients
Randall, C. L., Johnson, M., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., Brady, K. T., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1077 · Cited by 89
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence
Sousa, A. A. D., Sousa, J. D., & Kapoor, H. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.012 · Cited by 88
Donovan, D. M., Anton, R. F., Miller, W. R., Longabaugh, R., Hosking, J. D., & Youngblood, M. (2008) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2008.69.5 · Cited by 83
Individualised treatment in alcohol-dependent patients
Mann, K. F., & Hermann, D. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0153-7 · Cited by 79
Hides, L. M., Samet, S., & Lubman, D. I. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00207.x · Cited by 78
Smelson, D. A., Ziedonis, D. M., Williams, J. H. H., LOSONCZY, M. F., Williams, J. M., Steinberg, M. L., & Kaune, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000194624.07611.5e · Cited by 76
Bowen, R., D'Arcy, C., Keegan, D., & Senthilselvan, A. (2000) · Addictive Behaviours · doi:10.1016/s0306-4603(99)00017-9 · Cited by 76
A 12-year follow-up of a treated cocaine-dependent sample
Hser, Y., Stark, M. E., Paredes, A., Huang, D. Y. C., Anglin, M. D., & Rawson, R. A. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.12.007 · Cited by 73
The treatment of substance abusers diagnosed with obsessive–compulsive disorder: an outcome study
Fals-Stewart, W., & Schafer, J. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90032-j · Cited by 72
Leggio, L., Ray, L. A., Kenna, G. A., & Swift, R. M. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00982.x · Cited by 71
Exposure Therapy for Substance Abusers with PTSD: Translating Research to Practice
Coffey, S. F., Schumacher, J. A., Brimo, M. L., & Brady, K. T. (2004) · Behavior Modification · doi:10.1177/0145445504270855 · Cited by 70
First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder
Davidson, J. R. T. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.s.7002.05 · Cited by 69
Treatment of Schizophrenia and Comorbid Substance Use Disorder
Green, A. I., Salomon, M. S., Brenner, M. J., & Rawlins, K. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007024606230 · Cited by 68
Cocaine Abuse in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol
Sayers, S. L., Campbell, E. C., Kondrich, J., Mann, S. C., Cornish, J., O’Brien, C. P., & Caroff, S. N. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000165089.14736.bf · Cited by 67
Trafton, J. A., Minkel, J. D., & Humphreys, K. N. (2006) · Journal of Studies on Alcohol · doi:10.15288/jsa.2006.67.228 · Cited by 67
Naltrexone and Disulfiram in Patients With Alcohol Dependence and Current Depression
Petrakis, I., Ralevski, E., Nich, C., Levinson, C., Carroll, K., Poling, J., & Rounsaville, B. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b13e3180337fcb · Cited by 66
Relationship between anxiety disorders and opiate dependence— A systematic review of the literature
Fatseas, M., Denis, C., Lavie, E., & Auriacombe, M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.12.003 · Cited by 62
Wobrock, T., & Soyka, M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.02.008 · Cited by 62
Treatment Compliance in Patients with Comorbid Psychiatric and Substance Use Disorders
Herbeck, D. M., Fitek, D. J., Svikis, D. S., Montoya, I. D., Marcus, S. C., & West, J. C. (2005) · American Journal on Addictions · doi:10.1080/10550490590949488 · Cited by 62
Cannabis-Associated Psychosis: Current Status of Research
Leweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 61
Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius, J. R., Salloum, I. M., Thase, M. E., Haskett, R. F., Daley, D. C., Jones-Barlock, A., Upsher, C., & Perel, J. M. (1998) · PubMed · Cited by 60
Self-citationMarijuana Neurobiology and Treatment
Elkashef, A. M., Vocci, F. J., Huestis, M. A., Haney, M., Budney, A. J., Gruber, A. J., & el‐Guebaly, N. (2008) · Substance Abuse · doi:10.1080/08897070802218166 · Cited by 60
Substance abuse treatment for people with schizophrenia
Bellack, A. S., & Gearon, J. S. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00066-5 · Cited by 60
KAY‐LAMBKIN, F. J., Baker, A., & Lewin, T. J. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331324536 · Cited by 60
Castells, X., Kosten, T., Capellà, D., Vidal, X., Colom, J., & Casas, M. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990903108215 · Cited by 60
A Relapse Prevention Group for Patients with Bipolar and Substance Use Disorders
Weiss, R. D., Najavits, L. M., & Greenfield, S. F. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00011-7 · Cited by 59
Clinical Aspects of Substance Abuse in Persons with Schizophrenia
Negrete, J. C. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800104 · Cited by 59
Treatment of patients comorbid for addiction and other psychiatric disorders
Brady, K. T., Verduin, M. L., & Tolliver, B. K. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0048-0 · Cited by 58
Pharmacotherapy of Comorbid Mood, Anxiety, and Substance Use Disorders
Brady, K. T., & Verduin, M. L. (2005) · Substance Use & Misuse · doi:10.1080/10826080500294924 · Cited by 57
Fluoxetine versus placebo for the marijuana use of depressed alcoholics
Cornelius, J. R., Salloum, I. M., Haskett, R. F., Ehler, J. G., Jarrett, P. J., Thase, M. E., & Perel, J. M. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00050-1 · Cited by 56
Treating comorbid substance use disorders in schizophrenia
Lubman, D. I., King, J. A., & Castle, D. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261003689958 · Cited by 54
Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.
Brady, K. T., Sonne, S. C., Malcolm, R. J., Randall, C. L., Simpson, K., Dansky, B. S., Roberts, J. S., & Brondino, M. J. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.276 · Cited by 54
Gueorguieva, R. V., Wu, R., Donovan, D. M., Rounsaville, B. J., Couper, D. J., Krystal, J. H., & O’Malley, S. S. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.017 · Cited by 51
van Nimwegen, L. J. M., de Haan, L., van Beveren, N. J. M., van der Helm, M., van den Brink, W., & LINSZEN, D. H. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300610 · Cited by 51
Chen, S., Barnett, P. G., Sempel, J. M., & Timko, C. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.03.015 · Cited by 50
Flupenthixol Treatment for Cocaine Abusers with Schizophrenia: A Pilot Study
LEVIN, F. R., Evans, S. M., Coomaraswamy, S., Collins, E. D., Regent, N., & Kleber, H. D. (1998) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999809016902 · Cited by 50
What’s New in the Treatment of Cocaine Addiction?
Kampman, K. M. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0143-5 · Cited by 48
Berg, A. L., Sandahl, C., & Clinton, D. (2008) · Psychology and psychotherapy · doi:10.1348/147608308x297113 · Cited by 47
Initial depression and subsequent drinking during alcoholism treatment
Conner, K. R., Sorensen, S., & Leonard, K. E. (2005) · Journal of Studies on Alcohol · doi:10.15288/jsa.2005.66.401 · Cited by 47
Hjorthøj, C. R., Fohlmann, A., & Nordentoft, M. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.02.001 · Cited by 46
Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
Titievsky, J., Seco, G., Barranco, M., et al. (1982) · PubMed · Cited by 45
Hjorthøj, C. R., Fohlmann, A., & Nordentoft, M. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.02.003 · Cited by 45
Opioid Antagonists for Pharmacological Treatment of Alcohol Dependence – A Critical Review
Soyka, M., & Rösner, S. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030280 · Cited by 43
Antipsychotic Drug Treatment of Schizophrenic Patients with Substance Abuse Disorders
San, L., Arranz, B., & Martínez-Raga, J. (2007) · European Addiction Research · doi:10.1159/000104886 · Cited by 40
Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya, H. P. (2007) · PubMed · Cited by 39
van Zaane, J., van den Brink, W., Draisma, S., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05079gry · Cited by 39
Relationship Between Medication Adherence and Treatment Outcomes: The COMBINE Study
Zweben, A., Pettinati, H. M., Weiss, R. D., Youngblood, M., Cox, C. E., Mattson, M. E., Gorroochurn, P., & Ciraulo, D. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00743.x · Cited by 39
Dundon, W. D., Pettinati, H. M., Lynch, K. G., Xie, H., Varillo, K., Makadon, C., & Oslin, D. W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.010 · Cited by 39
Clinical treatment of obsessive compulsive disorder.
Pittenger, C., Kelmendi, B., Bloch, M. H., Krystal, J. H., & Coric, V. (2005) · PubMed · Cited by 37
Sevy, S. M., Robinson, D. G., Sunday, S. R., Napolitano, B. A., Miller, R., McCormack, J., & Kane, J. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.05.001 · Cited by 37
Patient depressive symptoms and therapist focus on emotional material: a new look at Project MATCH.
Karno, M. P., & Longabaugh, R. (2003) · Journal of Studies on Alcohol · doi:10.15288/jsa.2003.64.607 · Cited by 36
Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients.
Siris, S. G., Mason, S. E., Bermanzohn, P. C., et al. (1993) · PubMed · Cited by 36
Latt, N. C., Jurd, S. M., Tennant, C., Lewis, J., Macken, L., Joseph, A., Grochulski, A., & Long, L. (2011) · Australasian Psychiatry · doi:10.3109/10398562.2011.579971 · Cited by 33
Comorbid Mood, Psychosis, and Marijuana Abuse Disorders: A Theoretical Review
Wilson, N., & Cadet, J. L. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903182960 · Cited by 33
Management of Schizophrenia with Substance Use Disorders
Lybrand, J., & Caroff, S. N. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.09.002 · Cited by 31
Mood Stabilizers in the Treatment of Substance Use Disorders
Maremmani, I., Pacini, M., Lamanna, F., Pani, P. P., Perugi, G., Deltito, J. A., Salloum, I. M., & Akiskal, H. S. (2010) · CNS Spectrums · doi:10.1017/s1092852900027346 · Cited by 30
Petrakis, I. L., LESLIE, D. L., Finney, J. W., & Rosenheck, R. A. (2006) · American Journal on Addictions · doi:10.1080/10550490500419052 · Cited by 30
Managing ADHD in the Presence of Comorbid Substance Use Disorder
Upadhyaya, H. P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0607e15 · Cited by 30
Alessi, S. M., Rash, C. J., & Petry, N. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.001 · Cited by 29
McRae‐Clark, A. L., Sonne, S. C., Brady, K. T., Durkalski, V., & Palesch, Y. Y. (2004) · American Journal on Addictions · doi:10.1080/10550490490265325 · Cited by 29
Soyka, M., Aichmüller, C., von Bardeleben, U., Beneke, M., Gläser, T., Hornung-Knobel, S., & Wegner, U. (2003) · European Addiction Research · doi:10.1159/000068809 · Cited by 29
Labbate, L. A., Sonne, S. C., Randal, C. L., Anton, R. F., & Brady, K. T. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.03.015 · Cited by 28
Anxiety and substance use disorders: introduction to the special series
Zvolensky, M. J., & Schmidt, N. B. (2003) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2003.07.002 · Cited by 27
Sysko, R., & Hildebrandt, T. (2009) · European Eating Disorders Review · doi:10.1002/erv.906 · Cited by 26
Aase, D. M., Jason, L. A., & Robinson, W. L. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.05.002 · Cited by 26
Facilitating Involvement in Twelve-Step Programs
Donovan, D. M., & Floyd, A. S. (2008) · Recent developments in alcoholism · doi:10.1007/978-0-387-77725-2_17 · Cited by 25
Pharmacotherapy of patients with schizophrenia and substance abuse
Wobrock, T., & Soyka, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802694655 · Cited by 23
Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders
Smelson, D. A., Dixon, L. B., Craig, T., Remolina, S., Batki, S. L., Niv, N., & Owen, R. R. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00002 · Cited by 22
Pharmacotherapy for Alcohol-Related Disorders: What Clinicians Should Know
Mariani, J. J., & LEVIN, F. R. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490905697 · Cited by 22
Extended naltrexone and broad spectrum treatment or motivational enhancement therapy
Longabaugh, R., Wirtz, P. W., Gulliver, S. B., & Davidson, D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1615-3 · Cited by 21
The Case for High-Dose Motivational Enhancement Therapy
Polcin, D. L., Galloway, G. P., Palmer, J. O., & Mains, W. (2004) · Substance Use & Misuse · doi:10.1081/ja-120028494 · Cited by 20
Stulz, N., Gallop, R., Lutz, W., Wrenn, G., & Crits-Christoph, P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.08.009 · Cited by 19
Weinstock, J., Rash, C. J., & Petry, N. M. (2010) · Psychology of Addictive Behaviors · doi:10.1037/a0017542 · Cited by 19
Mancino, M. J., McGaugh, J., Feldman, Z., Poling, J. C., & Oliveto, A. H. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00025.x · Cited by 16
[Commentary] JOINING THE QUEUE OF DISSENTERS
Orford, J. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02128.x · Cited by 15
An update on the treatment of bipolar depression
Azorin, J., & Kaladjian, A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802653172 · Cited by 15
(2005) · Substance Use & Misuse · doi:10.1080/10826080500294791 · Cited by 12
Behavioral treatment of substance abuse in schizophrenia
Tenhula, W. N., Bennett, M. E., & Kinnaman, J. E. S. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20613 · Cited by 11
Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment
Magura, S., Rosenblum, A., & Betzler, T. F. (2009) · Substance Abuse Research and Treatment · doi:10.4137/sart.s3462 · Cited by 7
Cited by
Alcohol use disorder and depressive disorders
McHugh, R. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.01 · Cited by 517
Psychiatric comorbidities in alcohol use disorder
Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30222-6 · Cited by 444
Update on Typical and Atypical Antipsychotic Drugs
Meltzer, H. Y. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050911-161504 · Cited by 433
Frost, H., Campbell, P., Maxwell, M., O’Carroll, R. E., Dombrowski, S. U., Williams, B., Cheyne, H., Coles, E., & Pollock, A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204890 · Cited by 413
Integrated treatment of substance use and psychiatric disorders
Kelly, T. M., & Daley, D. C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774673 · Cited by 378
Self-citation
Metadata
- Authors
- Kelly, T. M., Daley, D. C., & Douaihy, A. B.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 37
- Issue
- 1
- Pages
- 11-24
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2067567375
- Cited by
- 284
- References
- 193
- FWCI
- 17.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.